






In Africa, women have had minimal
participation in biomedical research especially in clinical
trials despite the epidemiologic realities of the trends and
burden of diseases in the continent. The purpose of this
paper is to critically examine the challenges as well as
suggesting ways of over-coming them in recruiting and
retainingAfrican women in biomedical research.
Relevant biomedical research literatures on
Human Research Participants from Scirus, Pubmed and
Medline computerized search were critically evaluated
and highlighted. Information was also obtained from
research ethics training as well as texts and journals in the
medical libraries of the research ethics departments of the
Universities of Pretoria, Kwazulu-Natal, Johns Hopkins
Berman Institute of Bioethics Baltimore and Kennedy
Institute of Bioethics Georgetown University, Washington
DC.
Studies reviewed have shown that African
women have an unfair participation in biomedical
research. Efforts in enrolling and retaining women in
biomedical research are hampered by chain reactions of
events viz: gender perception, cultural barriers, ignorance
and  fear  of  adverse  event,  limited  autonomy  to  give
consent, lack of confidentiality especially in sensitive
trials, and improper research design.
Women need to participate in clinical trials
because of their different biological and physiological
make-up which require proper information about the
effects of drugs on their bodies. A variety of harm may
therefore ensue from failure to include adequate numbers
of women in biomedical research such as exposure to
ineffective treatment, occurrence of unexpected side-
effects and delayed diagnosis and early treatment of
disease.
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Introduction
In order to conduct biomedical research in an ethically
acceptable manner, the selection of participating
communities and individual must be fair and justified in
terms of the scientific goals of the research . Social and
cultural factors should be considered by the sponsors
and researchers to determine the vulnerability within
the community of individual who are either included or
excluded. While enrolling women in some biomedical
research may be acceptable in certain cases, others
may be very difficult considering the gender perception
in African context. In most African society, men believed
that childbearing is a way of keeping women from
infidelity therefore enrolling them in a research that may
involve the use of condoms and contraceptive pills will
be perceived as instruments to promote extramarital
relationship. Such type of research in our contemporary
African society will be frowned at and any woman who
dared to participate may end up with serious social and
communal reprisals. African women need to participate
in clinical trials because of their different biological and
physiological make-up which require proper information
about the effects of drugs on their bodies. Gender
inequity in biomedical research has resulted in research
outcome too small to yield meaningful information about
treatment and burden of disease on different groups.
Evidence has also shown that researchers' opinions
and findings differed in characterizing the prevalence of
some diseases such as AIDS, heart disease and lung
cancer among men and women. . There are also other
reasons African women should be recruited in clinical
trials, and they include, understanding the extent of the
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population are at highest and lowest risk, and
characterizing the clinical response of drug trials in
women in comparison to that of men. This in turn will
assist health policy makers to evaluate the allocation of
resources for more research, prevention, treatment, and
support services. It therefore means that in order to
conduct ethical, valid, and generalizable biomedical
research, enrolling women in such research represents
an important part of the study design that must be
fulfilled . Enrolling and retaining African women in
biomedical research in general term is not as easy as in
men, one must bear in mind and recognize that apart from
cultural background, women expectations and
requirements for participation in research may not be the
same as in men . In Africa, while men can make decisions
freely, women may lack the decision-making freedom to
participate in a research that addresses sensitive issues
such as sexual behavior. Also they may be burdened with
childcare, domestic work and limited mobility which often
affect their full participation. The purpose of this paper is to
critically examine the challenges as well as suggesting
ways of over-coming them in recruiting and retaining
African women in biomedical research.
For a research to involve the active participation of
women, the sponsors and the researchers should take a
look at the complex dynamics involved in the research
process considering not only the wider socioeconomic
context but also the cultural and religious meanings and
practices through which the individual and group engage
in health-seeking behaviour in Africa. The challenges
include Gender perception, Cultural bearers, Ignorance
and fear of adverse event, Informed Consent and
Confidentiality among other restrictive factors.
The African perception of gender is not entirely in the
same consonance with the Western definition. In African
concept, a woman is a woman as far as she has the
biological features of a woman which among other things
include her ability to bear children and exhibit feminine
features. This is to an extent in contrast to the Western
concept, which defines gender as a social construct and
sex as the biological disposition of individual.
Consequently, in Africa, a woman is seen as a weaker
sex, whose responsibility is to bear children and take care
of the home, they should therefore be protected. In most
African countries they are not involved in decision-making
even on matters that concerns them. This concept of
“woman” in Africa and the paternalistic stance of men had
1
4
Challenges in recruiting and retaining African
Women in Biomedical research
African conception of Gender:
led to a default position of excluding women from
research but only including them when it was deemed
absolutely necessary It is also important to note that
researchers are not exempted from this stereotype
gender default position in Africa while conducting
clinical research as most of their study designs and
methodologies often exclude women. The various and
intertwined aspects of gender roles and power
dynamics included women's fulfillment of roles as
mothers and caregivers are strong impediments to their
full participation in clinical research .
Cultural factors that present potential barriers to women
recruitment in clinical research in most African
community include the importance of strong traditional
family values often termed (familismo), respect toward
male figures (personalismo), the role of the father
(machismo), in family decision making . The issues of
, , and in family
decision making are potential barriers to clinical trial
recruitment involvingAfrica women, as they suggest the
need for the assent or consent of male heads of
household. A number of cultural norms relating to
gender roles and power dynamics constitute a serious
barrier to enrolling and retaining African women in
clinical research. Most researches requiring that
pregnancy and breast-feeding be avoided may place
undue stress upon participants in cultures that place
value on women's fertility . In most African society, men
believed that childbearing was a way of keeping women
from infidelity therefore enrolling them in a research that
may involve the use of condoms and contraceptive pills
will be perceived as instruments to promote
extramarital relationship. Such type of research in our
contemporaryAfrican society will be frowned at and any
woman who dared to participate may end up with
serious social and communal castigations.
women
often expressed concerns that participating in a
biomedical research might have negative side effects
on their reproductive health, including difficulties in
conceiving children, teratogenic effects on the fetus,







Ignorance and Fear ofAdverse Events
familismo personalismo machismo
:
Apart from family and communal protection,
. This is very important inAfrican socio-
cultural construct where barren women are more often
subjected to objects of ridicule in the community while
malformed babies are seen as punishment from the
offended gods as a result of transgression committed
by the parents of the child. Notwithstanding, women's
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concerns in biomedical research participation is entirely
not out of place because there may be uncertainties in the
out come of some clinical trial depending on the type of
study design especially where such research have not
been carried out on animals as seen in the thalidomide
experience  .
10
In some cases the effect of the trials on the
animals can not be extrapolated in humans because of
diversities in physio-genetic make up of animals in
comparison to that of humans.
In African countries, considering the cultural setting,
informed consent may not be individually based but an
issue of reaching a consensus where the family values
takes precedence over individual autonomy . Africa
women therefore, tend to be more vulnerable because of
their social status as such getting adequate informed
consent from them may be difficult. Obtaining consent is a
further challenge in women who lack formal education
and may not understand the uncertainty that exists within
the clinical trials which warrant translation to the local
language they will understand  . In the same vein, out of
the uncertainties in obtaining inform consent and the
need to conduct research trials without hitches, some
research designs, may abinitio exclude women from
participating. Also young mothers may be more hesitant
to expose themselves to various forms of risks and
therefore may not willingly give their consent  . There
could be proxy consent because of the cultural norms that
men can give consent or assent on behalf of their wives
which apparently result to mediated autonomy. In such
situation, the woman may at some points lose the
enthusiasm to continue with the research process.
It may be difficult to enroll women in clinical trials that have
substantial social risks especially in an environment
where ignorance and poverty is common place such as
seen in Africa. For example most women may be very
uncomfortable to participate in research that involves
sexual behaviour such as STD or HIV especially where
the research is conducted in centers that are in public
view because of the risk of public exposure. This concern
to public exposure is understandable especially in an
environment that lacks the modern concepts and attitude
towards sexual maters. Women may also be concerned
about their diagnostic test being disclosed. For them, any
breach of confidentiality can lead to increased
discrimination and harassment. They may be subjected
to violence or abandonment by their male partners or to
discrimination from their employers if they are seen
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Other Restrictive Conditions:
How to Overcome the Challenges
Researchers
These include among other things the study design and
methodology. A study that will warrant that participants
have many times to visit the research site especially
where multiple transportation is involved will have less
women willing to participate. This is because they may
find several visits to the research site more tasking, time
consuming and waste of money considering the
socioeconomic condition of mostAfrican countries.
To overcome these challenges, the key players in
biomedical research must have roles to play to ensure
that women are recruited and retained in clinical
research. These key players include: the researchers,
IRB or research ethics committee, the community and
the prospective research participants in this case the
woman.
The researchers should have to put aside the gender
perception of women in African construct that limit
women participation in clinical trials and understand the
importance of women participation in clinical trials. This
will assist them in designing a study that will not only
include men but also women especially in drug trials as
women have peculiar physio-biological body that differs
from that of men. They should also acknowledge that
cultural differences in women's rights can be extreme,
and that in-depth knowledge of the community, where
the trial is being conducted, is imperative to
understanding barri
o
advocate for the rights and protection of female trial
participants especially in the communities and
countries where the rights of the participants are
threatened. Prior to conducting research they should
determine the appropriate means to engage women in
research in an environment that frowns at women
participating in clinical trials. They should know that
when in doubt on the methods to employ they may seek
assistance from the existing human rights monitors and
social support organizations in the community. To make
the research site gender sensitive, researchers can
also provide privacy in terms of being neither seen nor
heard when for example interviews are conducted. In
the same line researchers should provide convenient
ers to women participation. This will
assist them in designing a research procedure that will
accommodate women participants taking into
consideration the cultural disposition of the community.
Researchers should not only incorporate, but als
overcoming cultural barriers requires innovative
strategies, best drawn from within the community and
Nigerian Journal of Medicine, Vol.19, No. 2 April - June 2010, ISSN 1115 2613
135
location for women participants as well as a reception
area and space that would be welcoming and volunteer
friendly.
evaluate gender
differences to determine safety, immunogenicity, and
efficacy of some drugs. Clinical research that does not
include sizeable number of women capable of generating
data that could give reliable and generalizable information
in comparable to male participants should not be
approved by IRB.
The community should be reoriented to change the
paternalistic perception of womanhood in African context.
Community advisory committee (CAC) may be formed to
establish dialogue (Dialogue ethics) to sensitize them on
the need to allow women to participate in research trials.
However, changing gender perception in Africa should be
a gradual process and there is a need to train many people
in Africa in research ethics as to assist in educating the
people on detrimental effect of discouraging women to
participate in clinical trials. Government and law makers in
collaboration with health policy makers should also
introduce a system that will empower women to be able to
make their own decisions on issue that concerns them
especially their health.
Community
Institutional Review Board (IRB)
IRB should ensure that research protocol include women
in a research where there is a need to
Women Participants
Conclusion
African women having been under gender intimidation
by men folks for long should take there destiny into their
hands and resist male dominance especially on issue
that directly concern their health. But this could be done
gradually by them changing their gender concept as
seen in African construct so that they can confidently
consent to participating in clinical researches.
In Africa, efforts in enrolling and retaining women in
biomedical research are hampered by chain reactions
of events viz: gender perception, cultural barriers,
ignorance and fear of adverse event, limited autonomy
to give consent, lack of confidentiality especially in
sensitive trials, and improper research design. These
represent serious challenges considering the fact that
Africa is at present burdened with so many diseases
that are of public health importance. Researchers and
other key players should therefore, ensure the
enrollment of women in clinical research where
necessary. Since the primary aim of research is to
provide scientific evidence leading to a change in health
policy or standard of care, it is imperative to determine
whether the intervention or therapy being studied
affects women or men or minority and their
subpopulations differently. This will assist health policy
makers to evaluate the allocation of resources for more
research, prevention, treatment and provision of drugs,
and support services taking cognizance of which group
within the population are at lowest and highest risk
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